Search results for "Intestinal histology"

showing 5 items of 5 documents

Guinea pig transglutaminase immunolinked assay does not predict coeliac disease in patients with chronic liver disease

2001

BACKGROUND—It has been suggested that serological screening for coeliac disease (CD) should be performed in patients with chronic unexplained hypertransaminasaemia.
AIMS—To evaluate the specificity for CD diagnosis of serum IgA antitissue transglutaminase (tTG) determination in consecutive patients with chronic hypertransaminasaemia using the most widely utilised ELISA based on tTG from guinea pig as the antigen.
PATIENTS AND METHODS—We studied 98 patients with chronic hypertransaminasaemia, evaluated for the first time in a hepatology clinic. Serum anti-tTG and antiendomysial (EmA) assays were performed. Patients positive for EmA and/or anti-tTG were proposed for intestinal biopsy. Finally…

AdultLiver CirrhosisMalemedicine.medical_specialtySettore MED/09 - Medicina InternaCirrhosisAdolescentHepatitis Viral HumanTissue transglutaminaseGuinea PigsAutoimmunityEnzyme-Linked Immunosorbent AssayChronic liver diseaseSensitivity and SpecificityCoeliac diseaseArticleStatistics NonparametricAntiendomysial antibodieIntestinal histologySerologyLiver diseaseIntestinal mucosaPredictive Value of TestsInternal medicinemedicineAnimalsHumansFalse Positive ReactionsTransaminasesAutoantibodiesTransglutaminasesCoeliac diseasebiologybusiness.industryAntitissue transglutaminase antibodieGastroenterologyHepatologyMiddle Agedmedicine.diseaseImmunoglobulin ACeliac DiseaseImmunologyChronic Diseasebiology.proteinLinear ModelsFemalebusinessLiver disease
researchProduct

Antiendomysium antibodies assay in the culture medium of intestinal mucosa: an accurate method for celiac disease diagnosis

2011

Background Celiac disease (CD) diagnosis is becoming more difficult as patients with no intestinal histology lesions may also be suffering from CD. Aim To evaluate the diagnostic accuracy of antiendomysium (EmA) assay in the culture medium of intestinal biopsies for CD diagnosis. Patients and methods The clinical charts of 418 patients with CD and 705 non-CD controls who had all undergone EmA assay in the culture medium were reviewed. Results EmA assay in the culture medium had a higher sensitivity (98 vs. 80%) and specificity (99 vs. 95%) than serum EmA/antibodies to tissue transglutaminase (anti-tTG) assay. All patients with CD who were tested as false-negatives for serum EmA and/or anti-…

AdultMalemedicine.medical_specialtyPathologySettore MED/09 - Medicina InternaAdolescentTissue transglutaminaseDuodenumBiopsyMuscle Fibers Skeletalceliac disease culture system diagnosis intestinal histology serum antiendomysiumDiseaseHuman leukocyte antigenGastroenterologyAntiendomysium antibodiesTissue Culture TechniquesYoung AdultIntestinal mucosaInternal medicineBiopsyMedicineHumansVillous atrophyIntestinal MucosaChildFalse Negative ReactionsAgedAutoantibodiesTransglutaminasesHepatologybiologymedicine.diagnostic_testbusiness.industryGastroenterologyInfantMiddle AgedCulture MediaCeliac DiseaseChild Preschoolbiology.proteinFemaleAntibodybusinessEpidemiologic MethodsBiomarkers
researchProduct

A difficult diagnosis of coeliac disease: Repeat duodenal histology increases diagnostic yield in patients with concomitant causes of villous atrophy

2018

Abstract Villous atrophy in absence of coeliac disease (CD)-specific antibodies represents a diagnostic dilemma. We report a case of a woman with anaemia, weight loss and diarrhoea with an initial diagnosis of seronegative CD and a histological documented villous atrophy who did not improve on gluten-free diet due to the concomitant presence of common variable immunodeficiency (CVID) and Giardia lamblia infection. This case report confirms that CD diagnosis in CVID patients is difficult; the combination of anti-endomysial antibodies (EmA-IgA), anti-tissue transglutaminase antibodies (tTG-IgAb) antibodies and total IgA is obligatory in basic diagnostic of CD but in CVID are negative. Further…

Adultmedicine.medical_specialtySettore MED/09 - Medicina InternaTissue transglutaminaseDuodenumGastroenterologyImmunoglobulin DCoeliac diseaseIntestinal histology03 medical and health sciencesGiardia lamblia infection0302 clinical medicineIntestinal mucosaInternal medicinemedicineHumansCoeliac disease; Common variable immunodeficiency; Giardia lamblia infection; Intestinal histology; Villous atrophyVillous atrophybiologyCoeliac diseasebusiness.industryCommon variable immunodeficiencyGastroenterologyHistologymedicine.diseaseCeliac DiseaseCommon Variable Immunodeficiency030220 oncology & carcinogenesisConcomitantbiology.protein030211 gastroenterology & hepatologyFemaleAtrophybusinessVillous atrophy
researchProduct

Clinical symptoms in celiac patients on a gluten-free diet.

2008

OBJECTIVE: Persistent villous atrophy in patients with celiac disease (CD) on a gluten-free diet (GFD) is reported with increasing frequency. The aim of this study was to evaluate a possible association between persistent damage of the villi and "atypical" gastrointestinal symptoms in CD patients on a GFD. MATERIAL AND METHODS: Sixty-nine CD patients on a GFD were divided into two groups: Group A included 42 patients (6 M, 36 F, age range 17-62 years) undergoing esophagogastroduodenoscopies (EGDs) due to the presence of symptoms; Group B included 27 control patients (6 M, 21 F, age range 24-71 years) who were asymptomatic at the time of the study. Both groups underwent EGDs and a duodenal h…

AdultMalemedicine.medical_specialtyAdolescentDiet therapyAsymptomaticGastroenterologyGroup BCoeliac diseaseEndoscopy GastrointestinalDiet Gluten-Freegluten-free dietInternal medicineImmunopathologymedicineHumansVillous atrophyIntestinal MucosaAgedbusiness.industryGastroenterologyOdds ratiointestinal histologyMiddle Agedmedicine.diseaseCeliac DiseaseTreatment OutcomesymptomsGluten freeFemalemedicine.symptombusinessScandinavian journal of gastroenterology
researchProduct

IgA anti-actin antibodies ELISA in coeliac disease: A multicentre study.

2007

Previous studies have demonstrated that serum anti-actin antibodies are a reliable marker of intestinal damage severity in coeliac disease.To validate in a multicentre study the clinical usefulness of serum IgA anti-actin antibody ELISA and its possible use in monitoring intestinal mucosa lesions during gluten-free diet.Four centres recruited 205 newly diagnosed coeliac disease patients with villous atrophy, 80 healthy controls and 81 "disease" controls. Twelve coeliac disease patients on gluten-free diet but with persistent symptoms underwent serum IgA anti-actin antibody assay and intestinal histology evaluation. IgA anti-actin antibody ELISA was performed with a commercial kit. All coeli…

AdultMalePathologymedicine.medical_specialtySettore MED/09 - Medicina InternaAdolescentEnzyme-Linked Immunosorbent AssaySerum igaDiseaseCommercial kitSensitivity and SpecificityCoeliac diseaseIgA anti-actin antibodies; coeliac disease; multicentre studyIntestinal mucosaHumansMedicineIntestinal MucosaVillous atrophyChildAgedAutoantibodiesHepatologybiologybusiness.industryGastroenterologyInfantnutritional and metabolic diseasesMiddle AgedIgA anti-actin antibodiemedicine.diseaseActinsmulticentre studyImmunoglobulin ACeliac DiseaseIntestinal histologyChild Preschoolbiology.proteinFemaleAntibodybusinessBiomarkerscoeliac disease
researchProduct